Heart Failure Clinical Trial
Precision Event Monitoring for Patients With Heart Failure Using HeartLogic
Summary
The goal of the PREEMPT-HF study is to collect device and clinical event data to evaluate extended applications of the HeartLogic Heart Failure Diagnostic (HeartLogic) in a broad spectrum of heart failure patients with an implantable cardioverter defibrillator or cardiac resynchronization therapy defibrillator. There are no primary safety and/or efficacy endpoints for this study.
Heart failure is a complex clinical syndrome with high morbidity, mortality, and economic burden. Chronic Heart Failure is persistent, gradually progressive, and punctuated by episodes of acute worsening leading to hospitalizations. Therefore, there remains an unmet clinical need to slow the progression of Heart Failure and prevent hospitalizations. HeartLogic, available in Boston Scientific cardiac resynchronization therapy devices and defibrillators, combines novel sensor parameters such as heart sounds and respiration with other measurements like thoracic impedance, heart rate, and activity into a HeartLogic Index for the early detection of worsening Heart Failure. However, there is limited data on the association of HeartLogic with the risk of Hear Failure readmissions and tachyarrhythmias, or for phenotyping the broad spectrum of Heart Failure patients.
Full Description
Subjects will be followed for approximately 12 months after the baseline visit to collect the required number of clinical events to support the study objectives. These events are called Reviewable Clinical Events, and include all-cause hospitalizations and Heart Failure outpatient visits.
Clinical event definitions are as follows:
Hospitalization (all-cause): the subject is admitted to inpatient hospital care and discharged on a different calendar date.
Heart Failure Hospitalization: the subject is admitted with signs/symptoms of congestive heart failure and receives unscheduled augmented Heart Failure therapy with oral or intravenous medications, ultrafiltration therapy or other parenteral therapy.
Heart Failure Readmission (30-day): the subject is admitted for an unplanned hospitalization for any cause within 30 days post discharge from a Heart Failure hospitalization.
Heart Failure Outpatient Visit: the subject has signs/symptoms of Congestive Heart Failure, and receives unscheduled intravenous decongestive therapy (e.g., Intravenous diuretics, Intravenous inotropes, Intravenous vasoactive drugs, ultrafiltration) in a setting that does not involve a hospitalization (e.g., emergency room, Heart Failure clinic, primary care clinic, etc.).
Eligibility Criteria
Inclusion Criteria:
Subject is age 18 or above, or of legal age to give informed consent specific to each country and national laws.
Subject has a documented diagnosis of heart failure.
Subject has a Boston Scientific Cardiac Resynchronization Therapy Defibrillator or Implantable Cardioverter Defibrillator device implant that has HeartLogic, with Heart Failure Sensors turned ON, Respiratory Sensor turned ON, and Sleep Incline Sensor turned ON.
Subject has an active bipolar right ventricle lead implant.
Subject is enrolled in LATITUDE (NXT 5.0 or future version), and is willing to be remotely monitored from the baseline visit for approximately 12 months with HeartLogic disabled.
Exclusion Criteria:
Subject has received or is scheduled to receive a heart transplant or ventricular assist device (VAD).
Subject is enrolled in any concurrent clinical study without prior Boston Scientific written approval (excluding registries).
Subject has a life expectancy of less than 12 months.
Subject has a history of non-compliance to medical care or known inability to comply with requirements of the clinical study protocol
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 55 Locations for this study
Birmingham Alabama, 35211, United States
Birmingham Alabama, 35294, United States
Jonesboro Arkansas, 72401, United States
Little Rock Arkansas, 72205, United States
Burbank California, 91505, United States
Mission Viejo California, 92691, United States
Stanford California, 94305, United States
Torrance California, 90502, United States
Torrance California, 90503, United States
Newark Delaware, 19713, United States
Jacksonville Florida, 32207, United States
Lakeland Florida, 33805, United States
Sarasota Florida, 34239, United States
Tallahassee Florida, 32308, United States
Winter Park Florida, 32792, United States
Chicago Illinois, 60605, United States
Chicago Illinois, 60612, United States
Evanston Illinois, 60201, United States
Springfield Illinois, 62701, United States
Urbana Illinois, 61801, United States
Iowa City Iowa, 52242, United States
Kansas City Kansas, 66160, United States
Bangor Maine, 04401, United States
Baltimore Maryland, 21201, United States
Boston Massachusetts, 02118, United States
Leominster Massachusetts, 01453, United States
Flint Michigan, 48532, United States
Kalamazoo Michigan, 49007, United States
Royal Oak Michigan, 48073, United States
Duluth Minnesota, 55805, United States
Saint Paul Minnesota, 55101, United States
Hattiesburg Mississippi, 39401, United States
Hattiesburg Mississippi, 39401, United States
Pontiac Missouri, 48341, United States
Saint Louis Missouri, 63110, United States
Albany New York, 12208, United States
Albany New York, 12211, United States
New York New York, 10032, United States
Rochester New York, 14642, United States
Chapel Hill North Carolina, 27599, United States
Canton Ohio, 44710, United States
Medford Oregon, 97504, United States
Portland Oregon, 97225, United States
Abington Pennsylvania, 19001, United States
Allentown Pennsylvania, 18103, United States
Pittsburgh Pennsylvania, 15213, United States
Greenville South Carolina, 29607, United States
Chattanooga Tennessee, 37403, United States
Nashville Tennessee, 37232, United States
Austin Texas, 78705, United States
Dallas Texas, 75390, United States
Pasadena Texas, 77505, United States
Tyler Texas, 75701, United States
Newport News Virginia, 23601, United States
Everett Washington, 98201, United States
Huntington West Virginia, 25701, United States
Chermside , , Australia
Aalst , , Belgium
Montréal , , Canada
Ste-Foy , , Canada
Aarhus , , Denmark
Caen , , France
Nantes , , France
Paris , , France
Saint-Priest-en-Jarez , , France
Bochum , , Germany
Lübeck , , Germany
Aberdeen , , Hong Kong
Hong Kong , , Hong Kong
Hong Kong , , Hong Kong
Waterford , , Ireland
Catanzaro , , Italy
Naples , , Italy
Negrar , , Italy
Verona , , Italy
Amsterdam , , Netherlands
Leiden , , Netherlands
Utrecht , , Netherlands
Barcelona , , Spain
Las Palmas , , Spain
Málaga , , Spain
Belfast , , United Kingdom
Clydebank , , United Kingdom
Dundee , , United Kingdom
Edinburgh , , United Kingdom
Manchester , , United Kingdom
Sheffield , , United Kingdom
Wolverhampton , , United Kingdom
How clear is this clinincal trial information?

Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.